Navigation Links
Injury Law Firm Releases New Informational Graphic on the Alleged Birth Defect Risks of Dangers of Topamax
Date:7/29/2013

(PRWEB) July 29, 2013

Topamax (topiramate) is a drug used to treat epilepsy and prevent migraines. It has also been used for off-label weight loss for many years and recently the FDA approved a combination of topiramate and phentermine for weight loss. In 1996, the FDA approved Topamax for manufacture and marketing by McNeil Pharmaceuticals and Janssen Pharmaceuticals, which are both owned by Johnson & Johnson. Since the drug’s introduction to the market, it has earned billions of dollars in sales. In fact, the FDA has reported that between January 2007 and December 2010 approximately 32.3 million prescriptions were filled by 4.3 million people (i).

In March 2011, the FDA issued a Drug Safety Communication about a potential link between Topamax use in pregnancy and birth defects. It stated that “there is an increased risk for the development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with topiramate (Topamax and generic products) during pregnancy.” The FDA also added the drug to Pregnancy Category D meaning “there is positive evidence of human fetal risk based on human data.” It based this change on data from the North American Antiepileptic Drug Pregnancy Registry and a previous analysis of adverse events (i). According to a June 2010 Safety Review of the drug, the FDA had received 67 reports of birth defects including 21 facial defects (11 reports of cleft lip/palate), 19 malformations, and 15 cardiovascular defects (ii). Women who have used this drug and given birth to a child with a birth defect should talk to a drug lawyer about filing a lawsuit.

Recent reports show that Johnson & Johnson had to pay a multi-million dollar settlement and now faces at least 75 birth defect lawsuits due to the promotion and selling of Topamax. In April 2010, the U.S. Department of Justice announced that Johnson & Johnson affiliates, Janssen and McNeil, agreed to pay an $81 million settlement. The agreement was reached in order to settle allegations that the companies had illegally promoted the drug for “unapproved” or “off-label” uses. The Department stated that this “unlawful marketing undermines the FDA’s important role in deciding which drugs are safe and effective for consumers and costs the taxpayers billions of dollars each year" (iii). Also, Johnson & Johnson acknowledged in its most recent annual report that it was facing at least 75 birth defect lawsuits related to this drug (iv).

The new informational graphic provides information on the drug’s side effects as well as a timeline. Visit the webpage and view the Topamax infographic. d’Oliveira & Associates is currently working with some of the more experienced Topamax lawyers in the country who are handling these birth defect lawsuits. Contact the law firm to receive a free legal consultation and there is no fee unless you receive a settlement or award. Call toll-free at 1-800-922-6878 or fill out a contact form on their website in confidence.

(i) Drug Safety Communication, March 4, 2011.
fda.gov/Drugs/DrugSafety/ucm245085.htm
(ii) Safety Review: Topirmate Use During Pregnancy, June 1, 2010.
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM272371.pdf
(iii) U.S. Department of Justice Press Release, April 29, 2010.
justice.gov/opa/pr/2010/April/10-civ-500.html
(iv) Johnson & Johnson 2012 Annual Report
files.shareholder.com/downloads/JNJ/2489818923x0x644760/85FD0CFF-2305-4A02-8294-2E47D0F31850/JNJ2012annualreport.pdf

Read the full story at http://www.prweb.com/releases/2013/7/prweb10942850.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Injury and Disability Lawyers Release New Informational Graphic about the Link Between Asbestos and Mesothelioma
2. Law School Student Wins Michigan Personal Injury Law Firm’s Diversity Scholarship
3. Injury Claims against Skechers Toning Shoes Settled or In Process, Says Attorney Robert Jenner
4. Injury Lawyers Release New Infographic and Video about the Antidepressant Zoloft and Its Alleged Dangers
5. Injury Law Firm Releases New Informational Graphic about Workers’ Compensation in Rhode Island
6. The Berman Law Firm Now Offers Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases in Kendall, FL
7. Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases Are Now Offered By The Berman Law Group in Delray Beach, FL
8. Michigan Personal Injury Lawyers Announce Winner of 2013 Buckfire & Buckfire Diversity Scholarship
9. Sunrise FL Car Accident Lawyers The Berman Law Firm Now Offer Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases
10. Mahir Reiss Issues Comment On Injury Prevention Strategies
11. Changes in hyaluronan metabolism key in adaptation of keratinocytes to radiation injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... 29, 2016 , ... Dr. Bernie Siegel, (M.D.) ... MEDICINE and MIRACLES") addresses touchy topics related to Death live on Dr. ... Dr. Bernie Siegel, author of a plethora of essential books-to-read for physicians and ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Conditions were ideal ... Cove Island Park on Sunday, with sunny skies, a light breeze and temperatures in ... $33,000. , The 5k Run and Walk and 1-mile walk were held ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... reveals that infants born with severe congenital diaphragmatic hernia have better survival rates ... with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, ...
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
(Date:4/27/2016)... Shire plc (LSE: SHP, NASDAQ: ... Financial Officer, will present at the Deutsche Bank 41st Annual ... on Wednesday, May 04, 2016, 10:00 am EDT (15:00 BST). ... the Presentations and Webcasts section of Shire,s Investor website at ... be available on this same website for approximately 90 days. ...
Breaking Medicine Technology: